| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Beximco Pharmaceuticals supply of Covid-19 vaccine from Serum Institute of India suffers delay
StockMarketWire.com
|
Beximco Pharmaceuticals said the first instalment of supply of Covid-19 vaccines from its partner Serum Institute of India had been delayed.
It remained unclear how long this delay will last, the company said.
The company previously agreed to import a further one million doses of the vaccine from SII, and had already received the first five million vaccine doses of a total of 30 million doses.
Beximco reiterated that the impact of importing and distributing the vaccine was still expected to 'have a material positive impact on the Company's full year results.'
At 9:43am: (LON:BXP) Beximco Pharmaceuticals Ltd share price was 0p at 81.5p
Story provided by StockMarketWire.com
|
|
|
|
|
|
